Kursprognose für Connect Biopharma Holdings Ltd (CNTB)CNTBConnect Biopharma Holdings Ltd

Alphio's CNTB stock price prediction model matches the current Connect Biopharma Holdings Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.73 (-0.04%). The 1-week path is $0.72 (-0.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Connect Biopharma Holdings Ltd is not a good buy right now due to its current price of $0.7771, which is significantly below its 52-week high of $3.82, indicating a steep decline of approximately 80%. The RSI of 28.565 suggests the stock is oversold, but the overall financial performance shows a troubling trend with a net income loss of $17,284,000 in the latest quarter. Furthermore, the forward P/E ratio of 0.7669 indicates potential undervaluation, but the company has not yet proven consistent revenue generation, with a year-to-date change of -69.16%. The main risk is the substantial net margin loss of -624.42% in the latest quarter, which raises concerns about the company's sustainability and ability to recover.

Connect Biopharma Holdings Ltd (CNTB) last closed at $0.7254, losing -0.86%. These facts feed the 1-day and 1-week CNTB price prediction above.